The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1632-1636.e2, June 2010

Infection after implantation of pulsatile mechanical circulatory support devices

  • William L. Holman, MD

      Affiliations

    • University of Alabama at Birmingham, Birmingham, Ala
    • Corresponding Author InformationAddress for reprints: William L. Holman, MD, Room 719 ZRB, 703 19th St S, Birmingham, AL 35294-0007.
  • ,
  • James K. Kirklin, MD

      Affiliations

    • University of Alabama at Birmingham, Birmingham, Ala
  • ,
  • David C. Naftel, PhD

      Affiliations

    • University of Alabama at Birmingham, Birmingham, Ala
  • ,
  • Robert L. Kormos, MD

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pa
  • ,
  • Patricia Desvign-Nickens, PhD

      Affiliations

    • National Heart, Lung, and Blood Institute, Rockville, Md
  • ,
  • Margarita T. Camacho, MD

      Affiliations

    • Newark Beth Israel Medical Center, Newark, NJ
  • ,
  • Deborah D. Ascheim, MD

      Affiliations

    • Mount Sinai School of Medicine, New York, NY

Received 29 September 2009; received in revised form 16 December 2009; accepted 2 January 2010. published online 05 April 2010.

Objective

INTERMACS is a registry of mechanical circulatory support devices sponsored by the National Institutes of Health. This analysis uses INTERMACS data to define the time course, incidence, and outcome of infection adverse events focusing on the first 3 months after implant.

Methods

Patients entered into INTERMACS from June 23, 2006, to September 30, 2008, were analyzed. Preimplant data (demographics, hemodynamics, and laboratory values), infection adverse events, and other outcomes were recorded. Infection adverse events were analyzed to compare infection rates in subgroups of patients and define risk factors for death.

Results

The analysis was confined to pulsatile mechanical circulatory support devices. A total of 593 patients from 88 institutions were entered. Infection was a relatively common event within the first 3 months of implant and was significantly (P = .005) more common in patients with biventricular assist devices than in patients with left ventricular assist devices, although the prevalence of infection equalized in months 4 to 12. Infection had a significant adverse effect on survival. Independent risk factors for death included support with a biventricular assist device, older age, severity of patient illness implantation of the device (INTERMACS level 1), and higher blood urea nitrogen.

Conclusions

Infection remains a relatively frequent adverse event and is associated with decreased survival. Interventions to prevent infection that focus on the preoperative and immediate postoperative periods are the ones most likely to achieve success by diminishing the incidence of infection during the initial 3 months after implantation. Rotary (continuous-flow) pumps are expected to have lower infection rates, but this remains to be seen.

CTSNet classification: 22, 27

Abbreviations and Acronyms: AE, adverse event, BiVAD, biventricular assist device, FDA, Food and Drug Administration, INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support, MCSD, mechanical circulatory support device, VAD, ventricular assist device

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: Margarita T. Camacho reports fees and grant support from Thoratec.

PII: S0022-5223(10)00046-2

doi:10.1016/j.jtcvs.2010.01.014

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1632-1636.e2, June 2010